Search

Author/Creator Eccles, Laura J.

1. Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227. Issue 6 (20th February 2023)

Authors:
Brahmer, Julie R.; Lee, Jong-Seok; Ciuleanu, Tudor-Eliade; Bernabe Caro, Reyes; Nishio, Makoto; Urban, Laszlo; Audigier-Valette, Clarisse; Lupinacci, Lorena; Sangha, Randeep; Pluzanski, Adam; Burgers, Jacobus; Mahave, Mauricio; Ahmed, Samreen; Schoenfeld, Adam J.; Paz-Ares, Luis G.; Reck, Martin;...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 6(2023)
Page Start:
1200
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis. (March 2023)

Authors:
O'Byrne, Kenneth; Popoff, Evan; Badin, Firas; Lee, Adam; Yuan, Yong; Lozano-Ortega, Greta; Eccles, Laura J.; Varol, Nebibe; Waser, Nathalie; Penrod, John R.; Goring, Sarah
Journal:
Lung cancer
Issue:
Volume 177(2023)
Page Start:
11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search